Norway Savings Bank Astrazeneca PLC Transaction History

Norway Savings Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 08, 2022	SELL	$55.72 - $67.12 $5,572 - $6,712	-100 Reduced 66.67%	50 $3,000
Q4 2021 Jan 18, 2022	BUY	$54.02 - $63.83 $2,701 - $3,191	50 Added 50.0%	150 $9,000
Q3 2021 Oct 14, 2021	BUY	$55.56 - $60.79 $5,556 - $6,079	100 New	100 $6,000
Q1 2018 Apr 10, 2018	SELL	$32.97 - $36.63 $8,242 - $9,157	-250 Closed	0 $0
Q3 2017 Oct 20, 2017	BUY	$28.96 - $34.0 $7,240 - $8,500	250	250 $8,000

1,358

512M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $234B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Norway Savings Bank, based on Form 13F filings with the SEC.

Stay updated on Norway Savings Bank with notifications on news.